Status:

COMPLETED

Chemopreventive Therapy for Malaria in Ugandan Children

Lead Sponsor:

University of California, San Francisco

Collaborating Sponsors:

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Conditions:

Malaria

Eligibility:

All Genders

4-5 years

Phase:

PHASE3

Brief Summary

Young African children living in high transmission areas suffer the greatest burden of malaria. In most African countries, such as Uganda, the only current preventive measure against malaria in high t...

Detailed Description

Convenience sampling will be used to enroll a cohort of 600 HIV-uninfected infants between the ages of 4-5 months of age according to the following strata based on the mother's HIV status: 1) 200 HIV-...

Eligibility Criteria

Inclusion

  • Age 4 -5 months
  • Confirmed HIV status of biological mother
  • Negative HIV DNA PCR test at time of enrollment for infants born to HIV-infected mothers
  • Infants born to HIV-infected mothers must be breastfeeding
  • Residency within 30km of the study clinic
  • Agreement to come to the study clinic for any febrile episode or other illness and avoid medications given outside the study protocol
  • Provision of informed consent by parent/guardian

Exclusion

  • History of allergy or sensitivity to TS, SP, or DP
  • Active medical problem requiring in-patient evaluation at the time of screening
  • Intention of moving more that 30km from the study clinic during the follow-up period
  • Chronic medical condition (i.e. malignancy) requiring frequent medical attention
  • Living in the same household as a previously enrolled study participant
  • QTc interval \> 450 msec
  • Other clinically significant ECG abnormalities such as arrhythmia, ischemia, or evidence of heart failure
  • Family history of Long QT syndrome
  • Current use of drugs that prolong the QT interval

Key Trial Info

Start Date :

June 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2014

Estimated Enrollment :

600 Patients enrolled

Trial Details

Trial ID

NCT00948896

Start Date

June 1 2010

End Date

April 1 2014

Last Update

November 24 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

IDRC Research Clinic -Tororo District Hospital

Tororo, Uganda

Chemopreventive Therapy for Malaria in Ugandan Children | DecenTrialz